Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lymphoma Immunotherapy, IO Combinations

Vikram Bhatt

MD

🏢University of Nebraska Medical Center🌐USA

Medical Oncologist

32
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Vikram Bhatt at Nebraska has contributed to exploring combinations of immunotherapy agents with targeted therapies (BTK inhibitors, BCL-2 inhibitors) in hematologic malignancies. His work on the immunomodulatory effects of BTK inhibitors and how they can be rationally combined with checkpoint blockade or bispecific antibodies to enhance anti-tumor immunity in lymphoma addresses the challenge of optimizing multi-agent regimens.

Share:

🧪Research Fields 研究领域

lymphoma CAR-T combination
ibrutinib immunotherapy
BTK inhibitor immunotherapy
lymphoma IO combinations
bispecific antibody lymphoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Vikram Bhatt 的研究动态

Follow Vikram Bhatt's research updates

留下邮箱,当我们发布与 Vikram Bhatt(University of Nebraska Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment